Search

Search Results
Results 7371 - 7380 of 17271 for Active treatment
  • News - 25 May 2026
    A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial.
  • Drug - 25 May 2026
    Consumer Medicine Information (CMI) about Tzield intended for persons living in Australia.
  • News - 21 May 2026
    Researchers from The University of Osaka find that only a small fraction of T cells may drive the robust anti-cancer response seen in breakthrough multiple myeloma immunotherapy.
  • Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Valdoxan intended for persons living in Australia.
  • Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Domion intended for persons living in Australia.
  • Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Calquence tablets intended for persons living in Australia.
  • News - 20 May 2026
    A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key features that may help predict which types of rare cancers are likely to...
  • News - 19 May 2026
    This Communications Biology study used intracranial EEG in 22 epilepsy patients to map how the human brain processes new images of faces and places within milliseconds.. It found that visual...
  • Drug - 19 May 2026
    Consumer Medicine Information (CMI) about Rozlytrek intended for persons living in Australia.
  • Drug - 19 May 2026
    Consumer Medicine Information (CMI) about Precedex/Precedex Ready To Use intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.